Related references
Note: Only part of the references are listed.Functional insights from biophysical study of TREM2 interactions with apoE and Aβ1-42
Daniel L. Kober et al.
ALZHEIMERS & DEMENTIA (2021)
The microglial lysosomal system in Alzheimer's disease: Guardian against proteinopathy
Zoe P. Van Acker et al.
AGEING RESEARCH REVIEWS (2021)
GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor proteinNL-F/NL-F knock-in mice
Muzhou Jiang et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis
Yun Chen et al.
NEURON (2021)
Nanotechnology as a therapeutic strategy to prevent neuropsychomotor alterations associated with hypercholesterolemia
Matheus Scarpatto Rodrigues et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
Evaluation of Aducanumab for Alzheimer Disease Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility
G. Caleb Alexander et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Microglial Function and Regulation during Development, Homeostasis and Alzheimer's Disease
Brad T. Casali et al.
CELLS (2021)
Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms
Yang Shi et al.
NEURON (2021)
Relationship Between Amyloid-β Deposition and Blood-Brain Barrier Dysfunction in Alzheimer's Disease
Dong Wang et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
Activated microglia mitigate Aβ-associated tau seeding and spreading
Maud Gratuze et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
David S. Knopman et al.
ALZHEIMERS & DEMENTIA (2021)
Tau Protein Interaction Partners and Their Roles in Alzheimer's Disease and Other Tauopathies
Jakub Sinsky et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Amyloid-beta-independent regulators of tau pathology in Alzheimer disease
Rik van der Kant et al.
NATURE REVIEWS NEUROSCIENCE (2020)
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease A Randomized Clinical Trial
Robert Howard et al.
JAMA NEUROLOGY (2020)
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients
Yan-Chao Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer's Disease Dementia in a Large National Survey
May A. Beydoun et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
IL-1β, IL-6, IL-10, and TNFα Single Nucleotide Polymorphisms in Human Influence the Susceptibility to Alzheimer’s Disease Pathology
Mirjana Babić Leko et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Role of dietary fatty acids in microglial polarization in Alzheimer's disease
Smita Eknath Desale et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
Ling Mao et al.
JAMA NEUROLOGY (2020)
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
Harald Hampel et al.
FRONTIERS IN IMMUNOLOGY (2020)
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline
Joanne Ryan et al.
NEUROLOGY (2020)
Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease
Zhangsen Huang et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2020)
The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
Aleksandra Deczkowska et al.
CELL (2020)
Neurobiology of COVID-19
Majid Fotuhi et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Neurological associations of COVID-19
Mark A. Ellul et al.
LANCET NEUROLOGY (2020)
Lipoic Acid and Fish Oil Combination Potentiates Neuroinflammation and Oxidative Stress Regulation and Prevents Cognitive Decline of Rats After Sepsis
Amanda Della Giustina et al.
MOLECULAR NEUROBIOLOGY (2020)
Invite Review - Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials
D. Boche et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System
Fernanda G. De Felice et al.
TRENDS IN NEUROSCIENCES (2020)
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease
Michael T. Heneka et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
High Cholesterol Diet Exacerbates Blood-Brain Barrier Disruption in LDLr-/- Mice: Impact on Cognitive Function
Jade de Oliveira et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Tau Protein and Its Role in Blood-Brain Barrier Dysfunction
Alena Michalicova et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review
Jong-Chan Park et al.
BMB REPORTS (2020)
2020 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2020)
The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Diseasea Critical Review
Marta Sochocka et al.
MOLECULAR NEUROBIOLOGY (2019)
Could Alzheimer's Disease Originate in the Periphery and If So How So?
Gerwyn Morris et al.
MOLECULAR NEUROBIOLOGY (2019)
The Involvement of NLRP3 on the Effects of Minocycline in an AD-Like Pathology Induced by -Amyloid Oligomers Administered to Mice
Michelle Lima Garcez et al.
MOLECULAR NEUROBIOLOGY (2019)
Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors
Stephen S. Dominy et al.
SCIENCE ADVANCES (2019)
Impact of Gold Nanoparticles on Amyloid β-Induced Alzheimer's Disease in a Rat Animal Model: Involvement of STIM Proteins
Mehdi Sanati et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Natural Compounds for Alzheimer's Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
Stephanie Andrade et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Natural Products in Alzheimer's Disease Therapy: Would Old Therapeutic Approaches Fix the Broken Promise of Modern Medicines?
Solomon Habtemariam
MOLECULES (2019)
INTREPAD A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
Pierre-Francois Meyer et al.
NEUROLOGY (2019)
Infection-Induced Systemic Inflammation Is a Potential Driver of Alzheimer's Disease Progression
Vijayasree V. Giridharan et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Impaired Peripheral Lymphatic Function and Cerebrospinal Fluid Outflow in a Mouse Model of Alzheimer's Disease
Sunkuk Kwon et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Modifiable Risk Factors for Alzheimer's Disease
George A. Edwards et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices
Haijun Wang et al.
CURRENT ALZHEIMER RESEARCH (2019)
Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice
Chaitanya Chakravarthi Gali et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment
Juciano Gasparotto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration
Aleksandra Deczkowska et al.
CELL (2018)
Inhibition of protein misfolding and aggregation by natural phenolic compounds
Zohra Dhouafli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes
Carmen Mecca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Alzheimer's Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs
Patrick L. McGeer et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
Li Zhong et al.
MOLECULAR NEURODEGENERATION (2018)
Microglial control of astrocytes in response to microbial metabolites
Veit Rothhammer et al.
NATURE (2018)
Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models
C. Y. Daniel Lee et al.
NEURON (2018)
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
Fuyuki Kametani et al.
FRONTIERS IN NEUROSCIENCE (2018)
Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
Cyril Laurent et al.
BIOMEDICAL JOURNAL (2018)
Inflammasome signalling in brain function and neurodegenerative disease
Michael T. Heneka et al.
NATURE REVIEWS NEUROSCIENCE (2018)
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
Brian Lawlor et al.
PLOS MEDICINE (2018)
Common Infections May Lead to Alzheimer's Disease
Yuyan Wang et al.
VIROLOGICA SINICA (2018)
New insights into the role of TREM2 in Alzheimer's disease
Maud Gratuze et al.
MOLECULAR NEURODEGENERATION (2018)
Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
Sara Bachiller et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer's Disease
Vo Van Giau et al.
NUTRIENTS (2018)
Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer's disease
Danielle S. Davies et al.
BRAIN PATHOLOGY (2017)
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
Ting Yang et al.
JOURNAL OF NEUROSCIENCE (2017)
Vitamin D and Its Analogues Decrease Amyloid-β (Aβ) Formation and Increase Aβ-Degradation
Marcus O. W. Grimm et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease
Yu Yamazaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
TREM2-Ligand Interactions in Health and Disease
Daniel L. Kober et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes
Li Wen et al.
JOURNAL OF NUTRITION (2017)
Gold nanoparticles prevent cognitive deficits, oxidative stress and inflammation in a rat model of sporadic dementia of Alzheimer's type
Alexandre Pastoris Muller et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk
Anastasia G. Efthymiou et al.
MOLECULAR NEURODEGENERATION (2017)
Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding
I. Moreno-Gonzalez et al.
MOLECULAR PSYCHIATRY (2017)
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Yang Shi et al.
NATURE (2017)
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease
Carmen Venegas et al.
NATURE (2017)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims et al.
NATURE GENETICS (2017)
The blood-brain barrier in Alzheimer's disease
Elena Zenaro et al.
NEUROBIOLOGY OF DISEASE (2017)
The sterile controversy on the amyloid cascade hypothesis
Marco Canevelli et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid β (1-42) in mice
Michelle Lima Garcez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
Limin Song et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Dementia-related agitation: a review of non-pharmacological interventions and analysis of risks and benefits of pharmacotherapy
Eo Ijaopo
TRANSLATIONAL PSYCHIATRY (2017)
Wnt/TLR Dialog in Neuroinflammation, Relevance in Alzheimer's Disease
Juan M. Zolezzi et al.
FRONTIERS IN IMMUNOLOGY (2017)
Alzheimer's Disease and the Amyloid-β Peptide
M. Paul Murphy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind
Roberta Ricciarelli et al.
CURRENT NEUROPHARMACOLOGY (2017)
The Infectious Etiology of Alzheimer's Disease
Marta Sochocka et al.
CURRENT NEUROPHARMACOLOGY (2017)
Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation
Francesca Regen et al.
CURRENT ALZHEIMER RESEARCH (2017)
The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism
Gernot Kleinberger et al.
EMBO JOURNAL (2017)
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease
Hadas Keren-Shaul et al.
CELL (2017)
The effect of systemic inflammation on human brain barrier function
Elliot Elwood et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
The blood-brain barrier in systemic inflammation
Aravinthan Varatharaj et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease
Claudia Balducci et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease
Alberto Serrano-Pozo et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Jose Joaquin Merino et al.
CURRENT ALZHEIMER RESEARCH (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research
Avinash Parimisetty et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation
Honghua Zheng et al.
NEUROBIOLOGY OF AGING (2016)
Assessment of the genetic variance of late-onset Alzheimer's disease
Perry G. Ridge et al.
NEUROBIOLOGY OF AGING (2016)
TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
Peng Yuan et al.
NEURON (2016)
Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
Harm J. van de Haar et al.
RADIOLOGY (2016)
Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models
Michael J. D. Daniels et al.
NATURE COMMUNICATIONS (2016)
The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia
Panos Roussos et al.
ALZHEIMERS & DEMENTIA (2015)
Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents
Sina Shadfar et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
Establishment and Dysfunction of the Blood-Brain Barrier
Zhen Zhao et al.
CELL (2015)
The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease
Erdinc Dursun et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
RESVERATROL DECREASES THE INSOLUBLE Aβ1-42 LEVEL IN HIPPOCAMPUS AND PROTECTS THE INTEGRITY OF THE BLOOD-BRAIN BARRIER IN AD RATS
H. F. Zhao et al.
NEUROSCIENCE (2015)
Revisiting the Mechanisms of CNS Immune Privilege
Antoine Louyeau et al.
TRENDS IN IMMUNOLOGY (2015)
The Blood-Brain Barrier
Richard Daneman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Does Infection-Induced Immune Activation Contribute to Dementia?
Tatiana Barichello et al.
AGING AND DISEASE (2015)
β-Amyloid: the key peptide in the pathogenesis of Alzheimer's disease
Xiaojuan Sun et al.
FRONTIERS IN PHARMACOLOGY (2015)
Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease
Sergio T. Ferreira et al.
ALZHEIMERS & DEMENTIA (2014)
Role of the Microbiota in Immunity and Inflammation
Yasmine Belkaid et al.
CELL (2014)
Pattern recognition receptors and central nervous system repair
Kristina A. Kigerl et al.
EXPERIMENTAL NEUROLOGY (2014)
Inflammation in neurodegenerative diseases-an update
Sandra Amor et al.
IMMUNOLOGY (2014)
Increased Susceptibility to Amyloid-β-Induced Neurotoxicity in Mice Lacking the Low-Density Lipoprotein Receptor
Jade de Oliveira et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke
Fan Yang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
Ye Zhang et al.
JOURNAL OF NEUROSCIENCE (2014)
Long-Term Systemic Inflammation and Cognitive Impairment in a Population-Based Cohort
Margarete A. Wichmann et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2014)
Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer's Disease: a Comparative Overview
Frederic Brosseron et al.
MOLECULAR NEUROBIOLOGY (2014)
Septic encephalopathy: does inflammation drive the brain crazy?
Felipe Dal-Pizzol et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2014)
Microglia change from a reactive to an age-like phenotype with the time in culture
Claudia Caldeira et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy
Shuko Takeda et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Innate immune activation in neurodegenerative disease
Michael T. Heneka et al.
NATURE REVIEWS IMMUNOLOGY (2014)
The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
Patrick L. McGeer et al.
ACTA NEUROPATHOLOGICA (2013)
Aspirin-Triggered Lipoxin A4 Stimulates Alternative Activation of Microglia and Reduces Alzheimer Disease-Like Pathology in Mice
Rodrigo Medeiros et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
V. Sagulenko et al.
CELL DEATH AND DIFFERENTIATION (2013)
Melatonin in Alzheimer's Disease
Li Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Omega-3 Fatty Acids Enhance Phagocytosis of Alzheimer's Disease-Related Amyloid-beta(42) by Human Microglia and Decrease Inflammatory Markers
Erik Hjorth et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage
Patrick Wunderlich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease
Michelle A. Erickson et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Systemic immune system alterations in early stages of Alzheimer's disease
Rongzhen Zhang et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Differential Relationships of Reactive Astrocytes and Microglia to Fibrillar Amyloid Deposits in Alzheimer Disease
Alberto Serrano-Pozo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
The NLRP3 Inflammasome in Alzheimer's Disease
Meng-Shan Tan et al.
MOLECULAR NEUROBIOLOGY (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Alzheimer brain-derived amyloid β-protein impairs synaptic remodeling and memory consolidation
Gilyana G. Borlikova et al.
NEUROBIOLOGY OF AGING (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pleiotropic Actions of Insulin Resistance and Inflammation in Metabolic Homeostasis
Justin I. Odegaard et al.
SCIENCE (2013)
Oligomeric amyloid β induces IL-1β processing via production of ROS: implication in Alzheimer's disease
B. Parajuli et al.
CELL DEATH & DISEASE (2013)
ω-3 Fatty Acids in the Prevention of Cognitive Decline in Humans
Tommy Cederholm et al.
ADVANCES IN NUTRITION (2013)
Inflammatory process in Alzheimer's Disease
Marco A. Meraz-Rios et al.
FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease
Sang-Sun Yoon et al.
BIOMOLECULES & THERAPEUTICS (2012)
TLR2 Is a Primary Receptor for Alzheimer's Amyloid β Peptide To Trigger Neuroinflammatory Activation
Shirong Liu et al.
JOURNAL OF IMMUNOLOGY (2012)
Proteolytic processing of Alzheimer's ss-amyloid precursor protein
Han Zhang et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Innate Immunity and the Etiology of Late-Onset Alzheimer's Disease
Piet Eikelenboom et al.
NEURODEGENERATIVE DISEASES (2012)
CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease
Karin Westin et al.
PLOS ONE (2012)
Leukocyte CCR2 Expression Is Associated with Mini-Mental State Examination Score in Older Adults
Lorna W. Harries et al.
REJUVENATION RESEARCH (2012)
Inflammation in Alzheimer Disease-A Brief Review of the Basic Science and Clinical Literature
Tony Wyss-Coray et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The Genetics of Alzheimer Disease
Rudolph E. Tanzi
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment
Rawan Tarawneh et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease
Darin Jaturapatporn et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Extended results of the Alzheimer's disease anti-inflammatory prevention trial
John C. Breitner et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Amyloid Precursor Protein Processing and Alzheimer's Disease
Richard J. O'Brien et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
Vitamin D-3-Enriched Diet Correlates with a Decrease of Amyloid Plaques in the Brain of A beta PP Transgenic Mice
Jin Yu et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer's Disease Model
Masashi Kitazawa et al.
JOURNAL OF IMMUNOLOGY (2011)
Alzheimer's Disease Brain-Derived Amyloid-β-Mediated Inhibition of LTP In Vivo Is Prevented by Immunotargeting Cellular Prion Protein
Andrew E. Barry et al.
JOURNAL OF NEUROSCIENCE (2011)
Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail'
Rudy J. Castellani et al.
JOURNAL OF PATHOLOGY (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Septic encephalopathy: Inflammation in man and mouse
Alexander Jacob et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Neuropathological Alterations in Alzheimer Disease
Alberto Serrano-Pozo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Adipokines in inflammation and metabolic disease
Noriyuki Ouchi et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Aβ Accelerates the Spatiotemporal Progression of Tau Pathology and Augments Tau Amyloidosis in an Alzheimer Mouse Model
David E. Hurtado et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
A Meta-Analysis of Cytokines in Alzheimer's Disease
Walter Swardfager et al.
BIOLOGICAL PSYCHIATRY (2010)
Overview of the immune response
David D. Chaplin
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Neuroinflammation in Alzheimer's Disease: Mechanisms, Pathologic Consequences, and Potential for Therapeutic Manipulation
Kenneth Hensley
JOURNAL OF ALZHEIMERS DISEASE (2010)
Role of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease
Dara L. Dickstein et al.
MOUNT SINAI JOURNAL OF MEDICINE (2010)
Staging anti-inflammatory therapy in Alzheimer's disease
Mathieu P. Lichtenstein et al.
FRONTIERS IN AGING NEUROSCIENCE (2010)
Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets
Christine Lohmann et al.
ATHEROSCLEROSIS (2009)
The blood-brain barrier in brain homeostasis and neurological diseases
Nicolas Weiss et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Clearance of Amyloid-beta Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimer's Disease
R. Deane et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Human Truncated Tau is Using a Different Mechanism from Amyloid-beta to Damage the Blood-Brain Barrier
Andrej Kovac et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Meta-analysis of linkage studies for Alzheimer's disease-A web resource
Amy W. Butler et al.
NEUROBIOLOGY OF AGING (2009)
Screening of innate immune receptors in neurodegenerative diseases: A similar pattern
Maryse Letiembre et al.
NEUROBIOLOGY OF AGING (2009)
High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice
L. Thirumangalakudi et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic
Sebastian Jimenez et al.
JOURNAL OF NEUROSCIENCE (2008)
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Annett Halle et al.
NATURE IMMUNOLOGY (2008)
Regulation of β-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's disease
R. P. Jaya Prasanthi et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Toll-like receptors 2 and 4 mediate A beta(1-42) activation of the innate immune response in a human monocytic cell line
Maria L. D. Udan et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Mid-life adiposity factors relate to blood-brain barrier integrity in late life
D. R. Gustafson et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Blood-brain barrier impairment in Alzheimer disease - Stability and functional significance
G. L. Bowman et al.
NEUROLOGY (2007)
Hyperglycemia in acute ischemic stroke: a vascular perspective
Sharyl R. Martini et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease
John E. Donahue et al.
ACTA NEUROPATHOLOGICA (2006)
Circulating biomarkers of cognitive decline and dementia
V Solfrizzi et al.
CLINICA CHIMICA ACTA (2006)
Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ
M Sastre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice
MT Heneka et al.
BRAIN (2005)
Inflammatory proteins in plasma and the risk of dementia - The Rotterdam study
MJ Engelhart et al.
ARCHIVES OF NEUROLOGY (2004)
Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway
RA Quintanilla et al.
EXPERIMENTAL CELL RESEARCH (2004)
Modulation of nuclear factor-κB activity by indomethacin influences Aβ levels but not ap precursor protein metabolism in a model of Alzheimer's disease
S Sung et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action
L Gasparini et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Clearing amyloid through the blood-brain barrier
BV Zlokovic
JOURNAL OF NEUROCHEMISTRY (2004)
Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-β peptide in rat brain:: a comparative, in vivo study versus vitamin C and E
S Rosales-Corral et al.
JOURNAL OF PINEAL RESEARCH (2003)
CD36 mediates the innate host response to β-amyloid
JB El Khoury et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease:: peripheral inflammation or signals from the brain?
F Licastro et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Share Paper
